About
OvuCon offers an over-the-counter medical device designed to accurately predict ovulation, helping couples conceive by determining the woman's fertile period. The company's device is powered by a proprietary sensor and a set of algorithms that accurately predict ovulation and provide a five-day fertile window, allowing for convenient and safe planning using a mobile phone. A proof of concept conducted in Hadasa Medical Center with 42 participants confirmed that OvuCon's product is capable of identifying a pattern of cervical mucus, with the fertile period easily detected by the company's algorithm starting on the second day after the peak and ending one day after the nadir.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is OvuCon's primary product?
- OvuCon offers an over-the-counter medical device designed to accurately predict ovulation, helping couples conceive by determining the woman's fertile period.
- When was OvuCon founded?
- OvuCon was founded in May 2015.
- What is the current operational status of OvuCon?
- OvuCon is currently inactive, having ceased operations in November 2019.
- Where is OvuCon's headquarters located?
- OvuCon's headquarters is located in Kiryat Ono, Israel.
- Which market did OvuCon target geographically?
- OvuCon targeted the Indian geographic market.
- What was the outcome of the proof of concept study for OvuCon's product?
- A proof of concept conducted in Hadasa Medical Center with 42 participants confirmed that OvuCon's product could identify a pattern of cervical mucus, with the fertile period detected by the company's algorithm starting on the second day after the peak and ending one day after the nadir.
- Who are the founders of OvuCon?
- The founders of OvuCon are Simon Dotan and Gidon Zundelevich.
- What is OvuCon's current funding stage?
- OvuCon is currently in the Pre-Funding stage.
- What was a notable news event for OvuCon in 2015?
- In November 2015, Priority Aviation Inc. announced a license for the Personal Fertility Assistant product technology.